RecruitingNCT06357130
Gynaecological Care for Transgender People in France in 2024.
Sponsor
University Hospital, Bordeaux
Enrollment
500 participants
Start Date
Jun 3, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- French-speaking transgender person (transgender women or transgender men)
- age ≥18 years
Exclusion Criteria1
- age \<18 years
Interventions
OTHERQuestionnaire
A flyer with QR code leading to the online questionnaire will be sent to trans associations and healthcare networks for distribution to the target population.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06357130